Women's Health
Molecular and genetic testing to support early detection, diagnosis, and management of women’s reproductive and gynecological conditions
Women’s health testing encompasses a range of molecular and genetic diagnostics designed to support early detection, prevention, and management of conditions unique to female reproductive and gynecological health. By providing accurate and timely insights, these tests empower women and their healthcare providers to make informed decisions throughout various life stages.
Human Papillomavirus (HPV) DNA Genotyping
Detection and identification of 28 types of HPV as below:
19 high-risk HPV | 9 low-risk HPV
The specimen will be tested by our qualified referral lab
Liquid-Based Cytology (LBC)
Second opinion | Abnormal result – 7 working days
Screens for abnormal cytological changes in the cervix (cervical cancer, pre-cancerous lesions, atypical cells and other cytological categories) using new cell collection technique.
The specimen will be tested by our qualified referral lab
FemCheck (Infectious Disease)
A PCR-based STD detection for most common STIs, namely: Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Ureaplasma urealyticum, Ureaplasma parvum Mycoplasma hominis & Mycoplasma genitalium
Infectious Disease (HSV, CMV)
This test uses Real-Time PCR technology to detect the presence of:
• Herpes Simplex Virus types 1 and 2 (Combined HSV-1 and HSV-2)
• Cytomegalovirus (CMV)
